Skip to main content
Erschienen in: Diabetologia 1/2006

01.01.2006 | Short Communication

The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes

verfasst von: E. Kousta, Z. Efstathiadou, N. J. Lawrence, J. A. R. Jeffs, I. F. Godsland, S. C. Barrett, C. J. Doré, A. Penny, V. Anyaoku, B. A. Millauer, E. Cela, S. Robinson, M. I. McCarthy, D. G. Johnston

Erschienen in: Diabetologia | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We assessed the impact of ethnic origin on metabolism in women following gestational diabetes mellitus (GDM).

Materials and methods

Glucose regulation and other features of the metabolic syndrome were studied at 20.0 (18.2–22.1) months (geometric mean [95% CI]) post-partum in women with previous GDM (185 European, 103 Asian-Indian, 80 African-Caribbean). They were compared with the same features in 482 normal control subjects who had normal glucose regulation during and following pregnancy.

Results

Impaired glucose regulation or diabetes by WHO criteria were present in 37% of women with previous GDM (diabetes in 17%), especially in those of African-Caribbean and Asian-Indian origin (50 and 44%, respectively vs 28% in European, p=0.009). BMI, waist circumference, diastolic blood pressure, fasting triglyceride and insulin levels, and insulin resistance by homeostatic model assessment (HOMA), were increased following GDM (p<0.001 for all, vs control subjects). Where glucose regulation was normal following GDM, basal insulin secretion (by HOMA) was high (p<0.001 vs control subjects). Irrespective of glucose regulation in pregnancy, Asian-Indian origin was associated with high triglyceride and low HDL cholesterol levels, and African-Caribbean with increased waist circumference, blood pressure, and insulin levels, together with insulin resistance and low triglyceride concentrations. Nonetheless, the GDM-associated features were consistent within each ethnic group. The metabolic syndrome by International Diabetes Federation criteria was present in 37% of women with previous GDM, especially in non-Europeans (Asian-Indian 49%, African-Caribbean 43%, European 28%, p=0.001), and in 10% of controls.

Conclusions/interpretation

Following GDM, abnormal glucose regulation and the metabolic syndrome are common, especially in non-European women, indicating a need for diabetes and cardiovascular disease prevention strategies.
Literatur
1.
2.
Zurück zum Zitat O'Sullivan JB (1991) Diabetes mellitus after GDM. Diabetes 40(Suppl 2):131–135PubMed O'Sullivan JB (1991) Diabetes mellitus after GDM. Diabetes 40(Suppl 2):131–135PubMed
3.
Zurück zum Zitat Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113PubMedCrossRef Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113PubMedCrossRef
4.
Zurück zum Zitat Report of The World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. The World Health Organization Report of The World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. The World Health Organization
5.
Zurück zum Zitat Kousta E, Lawrence NJ, Godsland IF et al (2003) Insulin resistance and β-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 59:289–297CrossRef Kousta E, Lawrence NJ, Godsland IF et al (2003) Insulin resistance and β-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 59:289–297CrossRef
6.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
7.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059–1062PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059–1062PubMedCrossRef
8.
Zurück zum Zitat Robinson S, Henderson AD, Gelding SV et al (1996) Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 44:277–284CrossRef Robinson S, Henderson AD, Gelding SV et al (1996) Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 44:277–284CrossRef
9.
Zurück zum Zitat Zoratti R, Godsland IF, Chaturvedi N, Crook D, Stevenson JC, McKeigue PM (2000) Relation of plasma lipids to insulin resistance, non-esterified fatty acid levels and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 49:245–252PubMedCrossRef Zoratti R, Godsland IF, Chaturvedi N, Crook D, Stevenson JC, McKeigue PM (2000) Relation of plasma lipids to insulin resistance, non-esterified fatty acid levels and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 49:245–252PubMedCrossRef
10.
Zurück zum Zitat Sinha B, Brydon P, Taylor RS, Hollins A, Munro A, Jenkins D, Dunne F (2003) Maternal ante-natal parameters as predictors of persistent post-natal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 20:382–386PubMedCrossRef Sinha B, Brydon P, Taylor RS, Hollins A, Munro A, Jenkins D, Dunne F (2003) Maternal ante-natal parameters as predictors of persistent post-natal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 20:382–386PubMedCrossRef
Metadaten
Titel
The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes
verfasst von
E. Kousta
Z. Efstathiadou
N. J. Lawrence
J. A. R. Jeffs
I. F. Godsland
S. C. Barrett
C. J. Doré
A. Penny
V. Anyaoku
B. A. Millauer
E. Cela
S. Robinson
M. I. McCarthy
D. G. Johnston
Publikationsdatum
01.01.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-0058-6

Weitere Artikel der Ausgabe 1/2006

Diabetologia 1/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.